Asian Value Stocks Priced Below Estimated Worth In November 2025

As global markets face challenges such as tech sell-offs and economic uncertainties, Asian stock markets are drawing attention with their potential for value investing. In this environment, identifying undervalued stocks—those trading below their estimated worth—can offer opportunities for investors looking to capitalize on market inefficiencies and long-term growth prospects.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Click here to see the full list of 291 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

OceanaGold (Philippines) (PSE:OGP)

Overview: OceanaGold (Philippines) Inc. is involved in the exploration, development, production, and utilization of gold, copper, silver, and other mineral resources in the Philippines with a market capitalization of ₱63.84 billion.

Operations: OceanaGold (Philippines) Inc. generates revenue through its activities in gold, copper, and silver mining and production within the Philippines.

Estimated Discount To Fair Value: 14.2%

OceanaGold (Philippines) is trading at ₱28, below its estimated fair value of ₱32.63, offering a 14.2% discount. Despite high share price volatility, earnings have grown significantly by 115.5% over the past year and are forecast to grow at 20.57% annually, outpacing the Philippine market's growth rate of 10.9%. Recent earnings show robust performance with Q3 sales increasing to US$141.7 million from US$102.1 million year-on-year, reflecting strong cash flow potential despite a dividend not well covered by earnings.

• According our earnings growth report, there's an indication that OceanaGold (Philippines) might be ready to expand.
• Click to explore a detailed breakdown of our findings in OceanaGold (Philippines)'s balance sheet health report.

Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016)

Overview: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. operates in the biotechnology sector, focusing on the production and sale of functional sugar products, with a market cap of CN¥8.88 billion.

Operations: Revenue segments for SHSE:605016 are not provided in the given text.

Estimated Discount To Fair Value: 14.7%

Shandong Bailong Chuangyuan Bio-Tech is trading at CN¥21.15, about 14.7% below its estimated fair value of CN¥24.79, indicating undervaluation based on cash flows. The company's earnings grew by 39.9% over the past year and are forecast to grow significantly at 23.73% annually, although slower than the overall Chinese market's growth rate of 27%. Recent results show robust performance with nine-month revenue reaching CN¥968.9 million and net income rising to CN¥264.63 million from the previous year, highlighting strong cash flow potential despite a dividend not well covered by free cash flows.

• Insights from our recent growth report point to a promising forecast for Shandong Bailong Chuangyuan Bio-Tech's business outlook.
• Unlock comprehensive insights into our analysis of Shandong Bailong Chuangyuan Bio-Tech stock in this financial health report.

Nanya New Material TechnologyLtd (SHSE:688519)

Overview: Nanya New Material Technology Co., Ltd specializes in the manufacturing, design, development, and sale of composite materials with a market capitalization of CN¥15.70 billion.

Operations: The company generates its revenue through the manufacturing, design, development, and sale of composite materials.

Estimated Discount To Fair Value: 17.1%

Nanya New Material Technology Ltd. is trading at CN¥69.57, approximately 17.1% below its fair value estimate of CN¥83.88, highlighting potential undervaluation based on cash flows. The company's earnings grew by 328.2% over the past year and are projected to grow significantly at 63.7% annually, outpacing the broader Chinese market's growth rate of 27%. Recent nine-month results show sales increased to CN¥3.66 billion with net income rising to CN¥158.1 million from the previous year, reflecting strong cash flow growth prospects despite recent share price volatility and low forecasted return on equity of 17.3%.

• Our expertly prepared growth report on Nanya New Material TechnologyLtd implies its future financial outlook may be stronger than recent results.
• Click here and access our complete balance sheet health report to understand the dynamics of Nanya New Material TechnologyLtd.

Where To Now?

• Get an in-depth perspective on all 291 Undervalued Asian Stocks Based On Cash Flows by using our screener here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com